🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research study is evaluating a new drug called IPI-145 in combination ...
Status
Active Not Recruiting
Location
Beth Isreal Deaconess Medical Center
Start Date
2014-06-27
Trial ID
NCT02158091
Treatments Being Tested
Carpal tunnel syndrome (CTS) is the most common nerve compression disease a...
Status
Completed
Location
USC; Musculoskeletal Sonography & Occupational Performance Laboratory
Start Date
2021-12-13
Trial ID
NCT05057754
Treatments Being Tested
In this trial, we aim to improve the outcomes of haplo cord transplant. Hap...
Status
Completed
Location
University of Chicago Medical Center
Start Date
2012-10-16
Trial ID
NCT01810588
Objective: To determine whether immersive virtual reality (VR) treatment in...
Status
Completed
Location
Multiple Locations
Start Date
2014-08-01
Trial ID
NCT04017091
Treatments Being Tested
This study will examine the effectiveness of treating advanced melanoma wit...
Status
Completed
Location
National Cancer Institute (NCI)
Start Date
2004-03
Trial ID
NCT00080353
Treatments Being Tested
RATIONALE: Giving low doses of chemotherapy before a donor stem cell transp...
Status
Terminated
Location
Blood and Marrow Transplant Group of Georgia
Start Date
2005-05
Trial ID
NCT00818961
The primary objectives will be to measure the safety and efficacy of alloge...
Status
Terminated
Location
Multiple Locations
Start Date
2007-07
Trial ID
NCT00814983
This study is designed as a Phase III, multicenter trial, comparing progres...
Status
Completed
Location
Yale University School of Medicine
Start Date
2005-12
Trial ID
NCT00329030
Treatments Being Tested
This is a feasibility and pilot study. Though large-scale online neurocogni...
Status
Recruiting
Location
McGill University Health Centre
Start Date
2021-08
Trial ID
NCT05025254
Treatments Being Tested
Omburtamab is a murine IgG1 monoclonal antibody, recognizing CD276 (also kn...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-03
Trial ID
NCT05063357
Treatments Being Tested